What's New at The Body
HIV/AIDS News You Can Use
January 10, 2002
Visual AIDS: A New Year of HIV+ ArtistsNew York-based artist George Kimmerling is this month's curator in the always-fascinating monthly Visual AIDS Web Gallery of art by HIV-positive artists. This month's gallery is called "Queer Body Politic(s)."
Treatment Cycling: Less Than PerfectA seven-day on/off treatment regimen has kept some carefully selected patients HIV-suppressed for more than a year. But these seemingly hopeful findings have many strings attached: In many patients, the regimen is likely to cause more harm than good. For the details, read this from AIDS Treatment News.
One Flu Over the Cuckoo's NestHaven't got your flu vaccine yet? Read through The Body's section on flu vaccines. It's never too late to get one!
Condoms for DummiesBrowse through this simple guide to condoms, chock full of helpful tidbits: Learn how to talk about condoms with your partner, how to respond to someone who's reluctant to use them, and a step-by-step guide to their use. Get it all courtesy of San Francisco AIDS Foundation.
Women Still Get Second-Rate TreatmentAlthough anti-HIV therapy has prolonged life and revolutionized care for many people living with HIV, women remain underrepresented in clinical trials; less knowledgeable than HIV-positive men about the latest antiretroviral therapies; and less likely to be recruited for studies by their medical providers. Read this and other news from our daily news update.
Greater Empowerment, Microbicide-StyleMicrobicides will give people who can't insist on condoms a way of protecting themselves from HIV and other STDs. A newly proposed government bill could substantially increase the U.S. government's investment in microbicide research and development. Read the details on how you can help get the bill passed!
Deny THIS, Denialists!Part two of an article by Bruce Mirken looking at the reliability of HIV testing. He not only covers HIV testing in depth, but also answers the arguments of AIDS "denialists" who claim that HIV tests are unreliable, that HIV has not been proven to exist, or that HIV does not cause AIDS. Read the details in AIDS Treatment News.
Government Assistance the Easy WayWhether you have a bank account or not, you can now have your government-assistance checks deposited electronically, rather than hauling your check to the bank and standing on line. Find out more on Electronic Transfer Accounts, courtesy of AIDS Project Los Angeles.
Tenofovir and Bone TroublesAlthough tenofovir is an exciting new drug for people looking for a third-line treatment plan, it also carries a risk of causing bone toxicity or impairment -- most likely caused by a phosphorus deficiency. AIDS Survival News' Kelly Williams and Guy Pujol offer some tips on tenofovir and how to compensate for this deficiency.
New "Ask the Experts" Forum at The Body!HIV positive? Got questions on understanding your laboratory test results? Viral load, resistance or liver test results got you stumped? Dr. Mark Holodniy and Dr. Susan Little are now available to answer your questions!
Eye Disease and HIVVarious eye-related problems do strike HIV-positive people, but advances in treatment have made such conditions much less of a concern. AIDS Project Los Angeles provides a rundown of the more common eye problems in people with HIV.
A Different Kind of "Evildoer"?Federal agents have stormed a West Hollywood building. People have gathered in the streets to watch. Is it a major raid on a U.S. terrorist cell? Have they found the anthrax mailer? Not exactly.
The Body's Top-Notch Conference CoverageRead The Body's stellar coverage of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Ten of the U.S.' most outstanding HIV specialists were on hand and brought back a variety of intriguing reports -- some of which are highlighted below.
If a decision is made to discontinue cytomegalovirus retinitis maintenance therapy, Dr. Brian Boyle reports, patients should be closely followed for evidence of a relapse.
Dr. Robert Frascino takes a look at surviving anemia and HIV disease.
An interesting study evaluated how well a "virtual phenotype" predicts the effects of RT mutations on resistance to abacavir and other HIV drugs. Read the results from Dr. Mark Holodniy.
New Findings on HIV-Kaposi's Sarcoma Link